APA (7th ed.) Citation

Liu, D., Zhao, L., Wang, Y., Wang, L., Wu, D., & Liu, Y. (2025). Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms. Pharmaceuticals (14248247), 18(12), 1890. https://doi.org/10.3390/ph18121890

Chicago Style (17th ed.) Citation

Liu, Da, Liting Zhao, Ying Wang, Lei Wang, Donglu Wu, and Yangyang Liu. "Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms." Pharmaceuticals (14248247) 18, no. 12 (2025): 1890. https://doi.org/10.3390/ph18121890.

MLA (9th ed.) Citation

Liu, Da, et al. "Berberine: A Rising Star in the Management of Type 2 Diabetes—Novel Insights into Its Anti-Inflammatory, Metabolic, and Epigenetic Mechanisms." Pharmaceuticals (14248247), vol. 18, no. 12, 2025, p. 1890, https://doi.org/10.3390/ph18121890.